Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia - Wikidata - awgldk - TriplyDB

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

http://www.wikidata.org/entity/Q34400095

about

Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease.Hippocampal interneurons are abnormal in schizophrenia.Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates Striatal molecular signature of subchronic subthalamic nucleus high frequency stimulation in parkinsonian rat.Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticula Serotonin hyperinnervation and upregulated 5-HT2A receptor expression and motor-stimulating function in nigrostriatal dopamine-deficient Pitx3 mutant mice.Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid.Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Emerging roles of epigenetic mechanisms in Parkinson's disease.New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors.Dopamine receptor agonists for Parkinson's disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia.Pramipexole induced place preference after L-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications.Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.Metabotropic glutamate receptors for Parkinson's disease therapy.Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease.Striatal histone modifications in models of levodopa-induced dyskinesia.Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.

P2860

Q22251215-5E60DD97-5D85-4CFA-90E0-16BD64E6BDF1 Q26768220-2BBCB642-E66A-481D-AC62-9AB4DAFEDACC Q27021464-F453B705-708A-4EBD-B6AD-A0C187B988FC Q27316872-D84FD7E5-88AD-4069-BD56-E7D1EEA2FBB8 Q30493275-985FD168-BC7E-4DFA-A6C8-1A3FEBE9E437 Q30503608-AA1323BF-2CDF-4A51-986A-71B8EE44F1F2 Q30594829-E2B0E1DC-C54E-47E8-AC07-590B797AA96C Q30833645-7DCF71DB-57CA-43E5-94A3-43C4D122ECAA Q33255884-54DC4E11-EF6A-427D-869F-0709E3FA283B Q33285975-EDE955AB-A63E-4DA4-9708-B5AACBFDE32F Q33758221-52BF798E-7D99-470B-82DF-607B09020A2C Q33917299-33B6DE91-C1F9-4126-8F84-3C59E0771399 Q34094008-A2638976-1A35-4197-8347-DD5A6C76B206 Q34200166-CB916A56-C9CD-480D-B793-79EA6B265ADA Q34403740-6D89D2B7-D77A-4C78-A141-3024C20E2E7E Q34542164-B4DB387D-EA46-4E0A-B5FA-69D8510FE76B Q34673205-076C3191-D613-47CB-9582-C3D8DF65CE91 Q35163198-7A605415-7BF2-4577-9CE0-78B12B2A5F5F Q35846784-E07E793A-73BF-4822-9659-FEA6ABA8C009 Q36680671-8F4D6C1B-54B5-4B4B-9387-39777F44BAD2 Q36727014-22BC0626-3100-4ACE-9FCB-F106046D2B3A Q37040535-E6DA4749-CC32-44A3-AFCD-31162922C4F0 Q37048087-A4064D16-B2B6-4E98-9878-7714CEB68710 Q37384351-86E8A50D-FC61-4E7D-809A-55E7E561FCF1 Q37924629-A706B313-4358-41EF-B4B0-F7FD969466C1 Q37926552-238E63DA-016A-4491-90CE-13F33E933BA0 Q37974709-D2681F55-61FB-4397-BC35-E803682C7C9D Q38169202-044D384C-80B6-4953-9A84-D8FCB7250D5C Q38262418-C5D9747E-DB21-4F9E-A85C-01E0A221EB0D Q38479031-85385118-BB2D-4A05-81BD-8A64172CEF9F Q39403550-03C16B92-AB7B-445A-B735-910156E31479 Q39801798-6438FF27-1E0B-4C6C-9D0E-9211BD68CCA3 Q41584434-92CAE491-F791-4574-9D85-FC2DC6629B66 Q41818450-CC2F1031-7F7D-46DE-A7D6-97F6FDAD6107 Q42434375-3C60BF82-9FF2-4583-81CC-234322DD4CB1 Q42539139-51964DF7-3ADC-4583-B214-0BBC80DAA808 Q42777922-A0430326-6549-4A28-8064-55BC047970D7 Q43067885-428F71E4-0668-4391-8159-4EB4392A14D6 Q44228322-F44C366A-67AF-4FD2-8D94-CE29636E2043 Q46778385-6EEC7789-BEAF-4BEB-AA39-E07013E4BE9D

P2860

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

http://www.wikidata.org/entity/Q34400095

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

name

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@ast

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@en

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@nl

type

label

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@ast

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@en

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@nl

prefLabel

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@ast

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@en

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@nl

P1433

Q34400095-B58EAEC7-8903-4420-9F6F-87AC6EAF8BA8

P1476

Q34400095-980A02B8-2F94-46B1-AFCE-3C567F28FC91

P2093

Q34400095-49A5E373-82C9-4371-904C-14C58DC6B95D

Q34400095-5FF7B3A1-E8F4-4603-A533-FEBD0BB3D5FB

Q34400095-7B024274-8AB3-49D4-9451-1A4BBDF2ACA4

Q34400095-D372AB7D-58A6-465C-9EF1-77FC087548DF

Q34400095-E6A4F71D-2474-4572-8629-F97AFAB1E5C3

P2860

Q34400095-017D5D80-4BDD-49CB-9D11-80FD59D9573B

Q34400095-018B9069-8739-4E0D-9220-C84A6990AB88

Q34400095-02351B34-A94A-4B2E-A9BF-A076841E55F0

Q34400095-0516441B-5FB1-430E-9947-69AD71FB5B95

Q34400095-068BA563-6BDE-402A-A100-155DB7A46D92

Q34400095-0B66DB39-2467-4567-B787-752C21B67D65

Q34400095-0EBA018B-0F78-4CCF-BCE2-3CF9B6F144C4

Q34400095-153CBD73-020B-42F7-8DF0-CD7A406FA4D1

Q34400095-18CE0DFE-2AA3-45F0-ACCD-21AFAC9ADE17

Q34400095-1F3BF37A-05CE-4CE7-8A1E-E1B74AB10EC0

P304

Q34400095-A76CEC5A-E722-4FC2-8D6B-4AA50164143F

P31

Q34400095-9870BF40-0194-4C1A-976D-E8EE25B06101

P356

Q34400095-E2EF5938-2C1B-4BF4-9653-F3286E548AA1

P433

Q34400095-DC847EA7-C7C8-4C30-939F-21621BB96091

P478

Q34400095-5BD8B776-7186-4367-9F8A-BB77AE8EE4ED

P50

Q34400095-6030848E-1C3D-41B0-B270-037B6F1FB813

Q34400095-727625F4-8B6D-417C-A247-75562817844B

Q34400095-7DC5CD22-F1A2-430D-9EB6-35FD1F37BA45

P577

Q34400095-D6CD0D6E-BE2B-426A-80F4-DDFD9690448E

P5875

Q34400095-37288E10-1D8C-440F-A893-57AFE7B67429

P698

Q34400095-331F8326-2CC0-400E-AF0B-DB42222AFED3

P921

Q34400095-57F47461-BB25-4519-87B8-176C46B83E3F

Q34400095-D29DD661-512C-4699-8310-335A760BD0D2

P932

Q34400095-7E35696B-C9CE-49C1-9B24-9C661C6C68DA

P356

J.NBD.2004.07.005

P1433

Neurobiology of Disease

P1476

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

@en

P2093

Andrzej Dekundy

http://www.w3.org/2001/XMLSchema#string

Christine Konradi

http://www.w3.org/2001/XMLSchema#string

M Angela Cenci

http://www.w3.org/2001/XMLSchema#string

Martin Lundblad

http://www.w3.org/2001/XMLSchema#string

Molly E Eaton

http://www.w3.org/2001/XMLSchema#string

P2860

Brain monoglyceride lipase participating in endocannabinoid inactivation

Significance analysis of microarrays applied to the ionizing radiation response

Cluster analysis and display of genome-wide expression patterns

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application

MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data

Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

The economics of ribosome biosynthesis in yeast

Creatine and creatinine metabolism

P304

219-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2004.07.005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Katarzyna Kuter

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8242205

http://www.w3.org/2001/XMLSchema#string

P698

15474360

http://www.w3.org/2001/XMLSchema#string

P921

P932

4208672

http://www.w3.org/2001/XMLSchema#string